Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
112 Cards in this Set
- Front
- Back
What is the prototype of the salicylates?
|
Aspirin
|
|
What are Ibuprofen and Indomethacin?
|
Nonselective NSAIDs
|
|
What is cyclooxygenase?
|
Converts arachidonic acid to prostaglandin precursors
|
|
What is the difference between COX-1 and COX-2?
|
COX-1 is expressed in non-inflammatory cells
COX-2 is expressed in activated lymphocytes, PMN's and other inflammatory cells |
|
Which form of COX do Aspirin and non-selective NSAIDs inhibit?
|
both COX-1 and COX-2
|
|
What's the difference main difference between Aspirin/nonselective NSAIDs and COX-2-selective inhibitors?
|
The NSAIDs inhibit the release of prostaglandins involved in the inflammatory response plus the PG's involved in normal homeostasis
COX-2 selectives block PG's involved in inflammation only *NSAIDs have a particularly harsh effect on the GI tract, and COX-2 selectives do not |
|
What is the difference between aspirin and other NSAIDs?
|
Aspirin IRREVERSIBLY inhibits COX
other NSAIDs Reversibly inhibit COX |
|
What is special about Aspirin's irreversible blockage of COX?
|
It irreversibly blocks the enzyme, rendering it ineffecive. Platelets can't make a new enzyme themselves, so you have to wait for that platelet to die and new ones to form, which takes a few days.
|
|
What is the effect of the LOW range does of Aspirin?
(<300 mg/day) |
Reduces platelet aggregation
|
|
What is the effect of the INTERMEDIATE range does of Aspirin?
(300-2400 mg/day) |
Antipyretic and analgesic effects
|
|
What is the effect of the HIGH range does of Aspirin?
(2400-4000 mg/day) |
Anti-inflammatory effect
|
|
What is the difference between Aspirin and salicylate (its active metabolite)?
|
Aspirin = acetylsalicylic acid, and irreversibly inhibits COX
Salicylate is a reversible non-selective inhibitos of COX |
|
What are the other NSAIDs used for mainly?
|
Mild to Moderate pain, esp. pain from musculoskeletal inflammation like arthritis or gout
|
|
What is the main use for Ketorolac?
|
As a systemic analgesic, not as an anti-inflammatory
|
|
Which NSAID is available parenterally?
|
Ketorolac
|
|
How are NSAIDs useful for patients with Primary Familial adenomatous polyposis?
|
Non-selective NSAIDs reduce polyp formation in these patients
|
|
Long-term use of NSAIDs reduces the risk of what cancer?
|
Colon Cancer
|
|
What side effects does aspirin have on non-allergic patients?
|
Gastric Upset:
- Gastric ulceration - Upper GI Bleeding Renal effects: - Acute renal failure - Interstitial nephritis |
|
What does Small doses of aspirin cause in pt's with aspirin hypersensitivity?
(esp. those assoc. w/ nasal polyps) |
Asthma from the increased leukotriene synthesis
|
|
What does Moderate doses of aspirin cause in pt's with aspirin hypersensitivity?
|
Tinnitus
Vertigo Hyperventilation Respiratory ALKALOSIS |
|
What does Very High doses of aspirin cause in pt's with aspirin hypersensitivity?
|
Metabolic ACIDOSIS
Dehydration Hyperthermia Collapse Coma Death |
|
A child has a viral infection, and the mother gives her aspirin. What is this child at increased risk for?
|
Reye's Syndrome:
serious rapid Liver degeneration + encephalopathy |
|
Side effects of other NSAIDs
|
GI disturbances + Renal damage
Esp. in renal damage pts, b/c these drugs are renally excreted, so renal impairment --> increased plasma levels |
|
Parenteral use of Ketorolac should be limited to how many hours?
|
72 hours b/c of risk of GI and renal damage with longer use
|
|
What side effects are seen with indomethacin?
|
Hematologic reactions
|
|
What is the advantage of COX-2 inhibitors?
|
Reduced risk of GI effects like gastric ulcers and serious GI bleeds
|
|
What effect do COX-2 selective inhibitors have on Renal function?
|
Carry the same risk of renal damage as nonselective COX inhibitors
|
|
What are examples of COX-2 inhibitors?
|
Celecoxib
Rofecoxib Valdecoxib |
|
What side effect do Rofecoxib and Valdecoxib have?
|
Increased risk of MI, stroke, and increased risk of arterial thrombosis.
|
|
Why do they increase risk for arterial thrombosis?
|
PGI2 promotes vasodilation and inhibits platelet aggregation, but TXA2 has opposite effects.
They may have a greater effect on PGI2 endothelial prostacyclin formation than on platelet thromboxane A2. |
|
This drug is the only over-the-counter non-anti-inflammatory analgesic commonly available in the US
|
Acetaminophen
|
|
This toxic prodrug, that is metabolized to Acetaminophen, is still available in the US
|
Phenacetin
|
|
MOA of Acetaminophen
|
WEAK COX-1 & 2 inhibitor in peripheral tissues -> lack of anti-inflammatory effect
May inhibit COX-3 in CNS |
|
Effects of Acetaminophen
|
Analgesic and Antipyretic agent
Lacks anti-inflammatory and antiplatelet effects |
|
Acetaminophen is effective for the same indications as what NSAID?
|
Intermediate-dose Aspirin
|
|
Therefore Acetaminophen is useful as a substitute for NSAIDs in which situation?
|
For children with Viral infection
& anyone with Aspirin intolerance |
|
Toxicity of Acetaminophen in therapeutic doses
|
Negligible most of the time
|
|
When does acetaminophen cause serious toxicity, and what does it cause?
|
In overdose, or pts with Liver impairment
Causes Hepatotoxicity |
|
MOA of Acetaminophen toxicity
|
Oxidation to cyctotoxic intermediates by Phase I P450 enzymes.
This occurs if substrates for phase II conjugation rxns (acetate and glucuronide) are lacking |
|
What do you give a person who has overdosed on Acetaminophen?
|
N-Acetyl Cysteine
|
|
What people are at increased risk for acetaminophen-induced hepatotoxicity
|
THose who regularly consume 3+ alcoholic drinks per day
|
|
What characteristic of DMARDs make them differ form NSAIDs that give them the name "disease modifying drugs"
|
Evidence shows slowing or even reversal of Joint damage, an effect never seen with NSAIDs
|
|
How long does it take for DMARDs to take full effect?
|
6 weeks - 6 months
|
|
What is the use of Corticosteroids?
|
Too toxic for routine chronic use, so only used for temporary contorl of severe exacerbations and only used long term if nothing else works
|
|
Of the DMARDs, which one is a "cytotoxic drug"?
|
Methotrexate
|
|
Which ones interfere with the activity of T Lymphocytes?
|
*Sulfasalazine
*Hydroxychloroquine *Cyclosporine Leflunomide Mycophenolate mofetil Abatacept |
|
Which ones interfere with B Lymphocytes activitty?
|
Rituximab
|
|
Which ones interfere with activity of Macrophages?
|
Gold Compounds
|
|
Which ones interfere with TNF-alpha?
|
*Infliximab
*Etanercept Adalimumab |
|
Which DMARD is usu given early in the course of RA to ameliorate progression?
|
Methotrexate
|
|
Toxicities of METHOTREXATE
(also used as anticancer rx) |
Nausea
Mucosal Ulcers Hematotoxicity Teratogenicity |
|
Toxicities of CYCLOSPORINE
(also used for Tissue transplantation) |
Nephrotoxicity
Hypertension Liver toxicity |
|
Toxicities of Hydroxychloroquine, CHLORIQUINE
(Also an anti-malarial) |
Rash
GI distrub Ocular Toxicity |
|
Toxicities of SULFASALAZINE
(also used for IBS) |
Rash
GI distrub Dizziness HA Leukopenia |
|
Toxicities of Anti-TNF-alpha drugs
INFLIXIMAB, ETANERCEPT, ADALIMUMAB (also for IBS) |
Macrophage-dependent infection like activ. of latent Tb
Form'n of Ab's to ds-DNA and ANA Vasculitis |
|
Toxicities of LEFLUNOMIDE
|
Teratogen
Hepatotoxicity GI Disturb Skin Rxns |
|
Toxicities of GOLD COMPOUNDS
|
Many adverse effects including Diarrhea
Dermatitis Hematologic rxns (Aplastic Anemia) |
|
Toxicities of PENICILLAMINE
(also a chelating agent) |
Many SE:
Proteinuria Dermatitis GI disturb Hemat. abnorms (Aplastic Anemia) |
|
What are the 3 treatment strategies for Gout?
|
1.) Reducing inflammation during acute attacks w/: Colchicine, NSAIDs, or Glucocorticoids
2.) Accel. renal excretion of Uric acid w/uricosuric drugs: Probenecid, or sulfinpyrazone 3.) Reducing conversion of Purines to Uric adic by xanthin oxidase: Allopurinol or Febuxostat |
|
MOA of indomethacin for Gout
|
Decreases prostaglandins
Inhibits crystal phagocytosis by macrophages |
|
MOA of Colchicine for Gout
|
Colchicine is a selective inhibitor of Microtubule assembly
It reduces leukocyte migration and phagocytosis. May also reduce production of leukotriene B4 and decrease free radical formation |
|
Which drug is a mitotic poison and why?
|
Colchicine b/c it reacts with Tubulin and interferes with mictrotubule assembly
|
|
Which drug is prefered for the treatment of Acute Gouty Arthritis
|
Indomethacin or a Glucocorticoid
|
|
Why not use Colphicine fo racute attacks?
|
Causes GI disturb, particularly Diarrhea
|
|
What's another use for colchicine?
|
Mediterranean Fever:
Unknown cause Fever, hepatitis, peritonitis, pleuritis, arthritis, amyloidosis |
|
Toxicities of indomethacin
|
Renal Damage and Bone marrow depression
|
|
Toxicity of Colchicine
|
Damage to Liver & Kidney
|
|
How much filtered Uric acid is reabsorbed in the kidney?
|
90%
|
|
What are 2 important Uricosuric agents?
|
Probenecid
Sulfinpyrazone |
|
MOA of Uricosuric agents
|
They are weak acids that compete with uric acid reabsorption by the weak acid transport mechanism in the proximal tubules and thus increase uric acid excretion
|
|
What effect do LOW doses of Uricosuric agents have on uric acid secretion?
|
At low doses they also compete with uric acid for SECRETION by the tubule, so can ELEVATE serum uric acid levels.
|
|
What drug used with uricosuric agents increases uric acid levels by competing w/its secretion?
|
Aspirin
|
|
How do uricosuriric agents affect other drugs?
|
They INHIBIT the secretion of a large number of other weak acids: Penicillin, methotrexate
|
|
What is the USE of Uricosuric agents?
|
to treat CHRONIC gout.
They are of no value for acute episodes |
|
Toxicity of Uricosuric agents
How do you prevent this? |
Can precipitate an attack of acute gout during early phase of their action.
Can be avoided by simultaneous admin. of Colchicine or Indomethacin |
|
Allergic potential for uricosuric agents
|
Since they are sulfonamides, they share allergenicity w/other sulfonamides: Diuretics, Antimicrobials, oral hypoglycemics
|
|
What is Xanthine oxidase?
|
Converts:
- hypoxanthine to xanthine - xanthine to uric acid - Allopurinol to Oxypurinol |
|
What is Oxypurinol?
|
an irreversible suicide inhibitor of the Xanthine oxidase
|
|
What is Febuxostat?
|
A nonpurine inhibitor of xanthine oxidase that is more selective than allopurinol and alloxanthine
More effective in lowering serum uric acid than allopurinol |
|
What is the effect of inhibiting Xanthine oxidase?
|
Increases conc. of the more soluble Hypoxanthine and Xanthine, and DECR. the concentration of Uric acid (less soluble)
Thus less likelihood of precipitation of uric acid crystals in joints & tissues |
|
What is the USE for Xanthine oxidase inhibitors?
|
Its withheld for 1-2 weeks after an acute episode of gouty arthritis.
Used as an adjunct to Cancer Chemo, to slow the formation of uric acid from purines released by the death of large #'s of cancer cells |
|
Toxicities of Allopurinol
|
GI upset
Rash Rarely: Peripheral neuritis Vasculitis BM dysfunction - aplastic anemia |
|
Allopurinol affects the metabolism of what 2 drugs?
|
Mercaptopurine
Azathioprine Both depend on xanthine oxidase for elimination |
|
Toxicities of Febuxostat
|
Liver function abnorms
Headache GI upset |
|
What is the main SE of Colchicine at the doses required?
|
Diarrhea
|
|
* MOA of NSAIDs
|
* Inhibit prostaglandin synthesis by inhibiting cyclo-oxygenase (cox)
|
|
* Difference between Aspirin and other NSAIDs
|
* Aspirin irreversibly inhibits cyclooxygenase
|
|
* Four main actions of NSAIDs
|
* Anti-inflammatory, analgesia, antipyretic and anti-platelet activity
|
|
* Agent used for closure of patent ductus arteriosus
|
* Indomethacin
|
|
* Aspirin is contraindicated in children with viral infection
|
* Potential for development of Reye's Syndrome
|
|
* SE of salicylates
|
* Tinnitus, GI Bleeding
|
|
* NSAID also available as an ophthalmic preparation
|
* Diclofenac
Ketoroac |
|
* NSAID available orally, IM, & ophthalmically
|
* Ketorolac
|
|
* NSAID used for acute condition, such as pre-op anesthesia and has limited duration of use (<5 days) due to nephrotoxicity
|
* Ketorolac
|
|
* Newer NSAID that selectively inhibits COX-2
|
* Celecoxib
|
|
* COX 2 inhibitors may have reduced risk of
|
* Gastric ulcers and GI bleeding
|
|
* COX 2 inhibitors should be used cautiously in patients with
|
* Pre-existing cardiac or renal disease
|
|
* Acetaminophen only has
|
* Antipyretic and analgesic activity
|
|
* SE of acetaminophen
|
* Hepatotoxicity
|
|
* Antidote for acetaminophen toxicity
|
* N-acetylcysteine
|
|
* DMARDs are slow acting drugs for
|
* Rheumatic Disease
|
|
* Initial DMARD of choice for pts with RA
|
* Methotrexate
|
|
* Drug offer used in combination with TNF-alpha inhibitors for RA
|
* Methotrexate
|
|
* Causes of bone marrow suppression
|
* Methotrexate
|
|
* SE of penicillamine
|
* Aplastic anemia & Renal toxicity
|
|
* Interferes with activity of T-lymphocytes
|
* Hydroxychloroquine
|
|
* Anti-malarial drug used in RA
|
* Hydroxychloroquine
|
|
* SE of Hydroxychloroquine
|
* Retinal destruction and dermatitis
|
|
* MOA of Leflunomide (newer agent)
|
* Inhibits dihydroorotate dehydrogenase which leads to decreased pyrimidine synthesis, decreased T cell proliferation and decreased antibody production by B cells
|
|
* Proteins that prevent action of TNF-alpha
|
* Adalimumab, infliximab, & etanercept
|
|
* Anti-rheumatic agent also used for ulcerative colitis
|
* Sulfasalazine
|
|
* Anti-rheumatic agent also used for Crohn's disease
|
* Infliximab
|